T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 5924-5930

  Su, Shao Bo ^a   Gao, Ji Liang ^c   Gong, Wang Hua ^b   Dunlop, Nancy M ^a   Murphy, Philip M ^c   Oppenheim, Joost J ^a   Wang, Ji Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; GLYCOPROTEIN GP 41; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUCINE ZIPPER PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM MOBILIZATION; CELL MIGRATION; CHEMOTAXIS; CONCENTRATION (PARAMETERS); HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKOCYTE MIGRATION; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; CALCIUM SIGNALING; CHEMOTAXIS, LEUKOCYTE; GTP-BINDING PROTEINS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; LEUCINE ZIPPERS; MOLECULAR SEQUENCE DATA; MONOCYTES; NEUTROPHILS; PEPTIDE FRAGMENTS; PHAGOCYTES; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOXIN; RECEPTORS, PEPTIDE;

EID: 0006677261     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Kowalski, M., J. Potz, L. Basiripour, T. Dorfman, W. C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodtoski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351.
2. Dimitrov, D. S., and C. C. Broder. 1997. Receptor-mediated HIV entry. In HIV and Membrane Receptors. Medical Intelligence Unit. Landes Bioscience, Austin, p. 124.
3. Berger, E. A. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS A(Suppl.):S3.
4. Chan, D. C., D. Pass, J. M. Berger, and P. S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263.
5. Lawless, M. K., S. Barney, K. I. Guthrie, T. B. Bucy, S. R. Petteway, Jr., and G. Merutka. 1996. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry 35: 13697.
6. Wild, C., J. W. Dubay, T. Greenwell, T. Baird, Jr., T. G. Oas, C. McDanal, E. Hunter, and T. Matthews. 1994. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA 91:12676.
7. Kazmierski, W. M., R. J. Hazen, A. Aulabaugh, and M. H. St. Clair. 1996. Inhibitors of human immunodeficiency virus type 1 derived from gp41 transmembrane protein: structure-activity studies. J. Med. Chem. 39:2681.
8. Chen, C. H., T. J. Matthews, C. B. McDanal, D. P. Bolognesi, and M. L. Greenberg. 1995. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J. Virol. 69:3771.
9. Sabatier, J. M., K. Mabrouk, M. Moulard, H. Rochat, J. Van Rietschoten, and E. Fenouillet. 1996. Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope. Virology 223:406.
10. Kliger, Y., A. Aharoni, D. Rapaport, P. Jones, R. Blumenthal, and Y. Shai. 1997 Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion: structure-function study. J. Biol. Chem. 272:13496.
11. Munoz-Barroso, I., S. Durell, K. Sakaguchi, E. Appella, and R. Blumenthal. 1998. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140:315.
12. Wang, J. M. H. Ueda, O. M. Z. Howard, M. C. Grimm, O. Chertov, X. Gong, W. Gong, J. H. Resau, C. C. Broder, L. O. Arthur, F. W. Ruscetti, and J. J. Oppenheim. 1998. HIV-1 envelope gp120 inhibits monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation. J. Immunol. 161:4309.
13. Ueda, H., O. M. Z. Howard, M. C. Grimm, S. B. Su, W. Gong, G. Evans, F. W. Ruscetti, J. J. Oppenheim, and J. M. Wang. 1998. HIV-1 gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes. J. Clin. Invest. 102:804.
14. Smith, P. D., K. Ohura, H. Masur, H. C. Lane, A. S. Fauci, and S. M. Wahl. 1984. Monocyte function in the acquired immune deficiency syndrome: defective chemotaxis. J. Clin. Invest. 74:2121.
15. Prossnitz, E. R., and R. D. Ye. 1997. The N-formyl peptide receptor a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74:73.
16. Murphy, P. M. 1996. The N-formyl peptide chemotactic receptors. In: Chemoattractant ligands and Their Receptors. CRC Press, Boca Raton, p. 269.
17. Gao, J. L., and P. M. Murphy, 1993. Species and subtype variants of the JV-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 268:25395.
18. Gong, W., O. M. Howard, J. A. Turpin, M. C. Grimm, H. Ueda, P. W. Gray, C. J. Raport, J. J. Oppenheim, and J. M. Wang. 1998. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J. Biol. Chem. 273:4289.
19. Gong, X., W. Gong, D. B. Kuhns, A. Ben-Baruch, O. M. Howard, and J. M. Wang. 1997. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J. Biol. Chem. 272:11682.
20. Ben-Baruch, A., L. Xu, P. R. Young, K. Bengali, J. J. Oppenheim, and J. M. Wang. 1995. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3. J. Biol. Chem. 270:22123.
21. Murphy, P. M., and D. McDermott. 1991. Functional expression of the human formyl peptide receptor in Xenopus oocytes requires a complementary human factor. J. Biol. Chem. 266:12560.
22. Murphy, P. M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immuno. 12:593.
23. Oppenheim, J. J., C. O. Zachariae, N. Mukaida, and K. Matsushima. 1991. Prop-erties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617.
24. Gao, J. L., E. L. Becker, R. J. Freer, N. Muthukumaraswamy, and P. M. Murphy. 1994. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide cheraotactic receptor. J. Exp. Med. 180:2191.
25. Schiffmann, E., B. A. Corcoran, and S. M. Wahl. 1975. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl. Acad. Sci. USA 72:1059.
26. Carp, H. 1982. Mitochondrial N-formylmethionyl proteins as chemoaltractants for neutrophils. J. Exp. Med. 155:264.
27. Freer, R. J., A. R. Day, N. Muthukumaraswamy, D. Pinon, A. Wu, H. J. Showell, and E. L. Becker. 1982. Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils. Biochemistry 21:257.
28. Higgins, J. D., III, G. J. Bridger, C. K. Derian, M. I. Beblavy, P. E. Hernandez, F. E. Gaul, M. J. Abrams, M. C. Pike, and H. F. Solomon. 1996. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor. J. Med. Chem. 39:1013.
29. Derian, C. K., H. F. Solomon, J. D. Higgins III, M. J. Beblavy, R. J. Santulli, G. J. Bridget, M. C. Pike, D. J. Kroon, and A. J. Fischman. 1996. Selective inhibition of N-forrnylpeptide-induced neutrophil activation by carbamate-modified peptide analogues. Biochemistry 35:1265.
30. Murphy, P. M., T. Ozcelik, R. T. Kenney, H. L. Tiffany, D. McDermott, and U. Francke. 1992. A struclural homologue of the N-formyl peptide receptor: characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267:7637.
31. Ye, R. D., S. L. Cavanagh, O. Quehenberger, E. R. Prossnitz, and C. G. Cochrane. 1992. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184:582.
32. Nomura, H., B. W. Nielsen, and K. Matsushima. 1993. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Int. Immunol. 5:1239.
33. Bao, L., N. P. Gerard, R.L. Eddy, Jr., T.B. Shows, and C. Gerard. 1992. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 13:437.
34. Durstin, M., J. L. Gao, H. L. Tiffany, D. McDermott, and P. M. Murphy. 1994. Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes. Biochem. Biophys. Res. Commun. 201:174.
35. Gronert, K., A. Gewirtz, J. L. Madara, and C. N. Serhan. 1998. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (1L)-13 and interferon γ and inhibits tumor necrosis factor α-induced IL-8 release. J. Exp. Med. 187:1285.
36. Su, S. B., W. Gong, J-L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G-protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:395.
37. Badolato, R., J. M. Wang, W. J. Murphy, A. R. Lloyd, D. F. Michiel, L. L. Bausserman, D. J. Kelvin, and J. J. Oppenheim. 1994. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180:203.
38. Badolato, R., J. A. Johnston, J. M. Wang, D. McVicar, L. L Xu, J. J. Oppenheim, and D. J. Kelvin. 1995. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J. Immunol. 155:4004.
39. Fiore S., J. F. Maddox, H. D. Perez, and C. N. Serhan. 1994. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180:253.
40. Samuelsson, B., S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171.
41. Lee, T. H., P. Lympany, A. E. Crea, and B. W. Spur. 1991. Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships. Biochem. Biophys. Res. Commun. 180:1416.
42. Colgan, S. P., C. N. Serhan, C. A. Parkos, C. Delp-Archer, and J. L. Madara 1993. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92:75.
43. Takano, T., S. Fiore, J. F. Maddox, H. R. Brady, N. A. Pelasis, and C. N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185:1693.
44. 2+ mobilization. J. Immunol. 157:2149.
45. Maddox, J. F., M. Hachicha, T. Takano, N. A. Petasis, V. V. Fokin, and C. N. Serhan. 1997. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocyles and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 272:6972.
46. Ali, H., R. M. Richardson, E. D. Tomhave, J. R. Didsbury, and R. Snyderman. 1993. Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization. J. Biol. Chem. 268:24247.
47. Ali, H., E. D. Tomhave, R. M. Richardson, B. Haribabu, and R. Snyderman. 1996. Thrombin primes responsiveness of selective chemoattractant receptors at a site distal to G protein activation. J. Biol. Chem. 271:3200.
48. Abramson, J. S., and J. G. Wheeler. 1994. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr. Infect. Dis. J. 13:643.
49. Valone, F. H., D. G. Payan, D. I. Abrams, and E. J. Goetzl. 1984. Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. J. Infect. Dis. 150:267.
50. Meddows-Taylor, S., D. J. Martin, and C. T. Tiemessen. 1998. Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis. J. Infect. Dis. 177:921.
51. Ellis, M., S. Gupta, S. Galant, S. Hakim, C. VandeVen, C. Toy, and M. S. Cairo. 1988. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J. Infect. Dis. 158:1268.
52. Adamson, D. C., B. Wildemann, M. Sasaki, J. D. Glass, J. C. McArthur, V. I. Christov, T. M. Dawson, and V. L. Dawson. 1996. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274:1917.
53. Nara, P. L., R. R. Garrity, and J. Goudsmit. 1991. Neutralization of HIV-1: a paradox of humoral proportions. FASEB J. 5:2437.